Jodie Abramovitch

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Atopic Dermatitis

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy 79 (2) (2023)
Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy (2023)
Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy 79 (2) (2023)
Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy 79 (2) (2023)